Patents by Inventor Heikki Mansikka

Heikki Mansikka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210085673
    Abstract: The present invention provides a method of providing pain relief in a human subject in need thereof comprising administering (R)-dihydroetorphine to said subject, wherein said (R)-dihydroetorphine is administered in a dose of at least 0.01 ?g/kg, preferably at least 0.05 ?g/kg, and the level of respiratory depression in said subject is 65 or less % relative to the baseline level pre-administration of (R)-dihydroetorphine.
    Type: Application
    Filed: September 30, 2020
    Publication date: March 25, 2021
    Applicant: EURO-CELTIQUE S.A.
    Inventors: John WATKINS, Alexander Oksche, Kevin Smith, Heikki Mansikka, Paul Bailey
  • Patent number: 10898479
    Abstract: The present invention provides a method of providing pain relief in a human subject in need thereof comprising administering (R)-dihydroetorphine to said subject, wherein said (R)-dihydroetorphine is administered in a dose of at least 0.01 ?g/kg, preferably at least 0.05 ?g/kg, and the level of respiratory depression in said subject is 65 or less % relative to the baseline level pre-administration of (R)-dihydroetorphine.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: January 26, 2021
    Assignee: Euro-Celtique S.A.
    Inventors: John Watkins, Alexander Oksche, Kevin Smith, Heikki Mansikka, Paul Bailey
  • Publication number: 20160002326
    Abstract: The treatment of rheumatoid arthritis using engineered multivalent and multispecific binding proteins that target TNF and IL-17 is provided.
    Type: Application
    Filed: June 10, 2015
    Publication date: January 7, 2016
    Inventors: Carolyn Cuff, Robert Caldwell, Renee Heuser, Heikki Mansikka, Robert J. Padley